| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neural Stem Cells | 12 | 2025 | 130 | 3.950 |
Why?
|
| Hippocampus | 19 | 2025 | 772 | 3.570 |
Why?
|
| Neurogenesis | 14 | 2025 | 206 | 2.660 |
Why?
|
| Metabolomics | 8 | 2023 | 456 | 2.000 |
Why?
|
| Neurons | 17 | 2023 | 1908 | 1.740 |
Why?
|
| Brain | 16 | 2026 | 3021 | 1.550 |
Why?
|
| Magnetic Resonance Spectroscopy | 9 | 2023 | 277 | 1.470 |
Why?
|
| Stem Cells | 8 | 2018 | 678 | 1.420 |
Why?
|
| Biomarkers | 7 | 2025 | 3143 | 0.980 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 3 | 2025 | 270 | 0.920 |
Why?
|
| Phagocytosis | 3 | 2020 | 191 | 0.910 |
Why?
|
| Organoids | 2 | 2024 | 282 | 0.890 |
Why?
|
| Astronauts | 1 | 2022 | 38 | 0.750 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2023 | 209 | 0.720 |
Why?
|
| Receptors, Notch | 3 | 2018 | 195 | 0.710 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2024 | 3573 | 0.700 |
Why?
|
| Radiation Injuries | 1 | 2022 | 136 | 0.700 |
Why?
|
| Glycosyltransferases | 3 | 2018 | 27 | 0.700 |
Why?
|
| Computational Biology | 1 | 2025 | 839 | 0.660 |
Why?
|
| Animals | 34 | 2025 | 33185 | 0.590 |
Why?
|
| Drosophila melanogaster | 2 | 2023 | 822 | 0.570 |
Why?
|
| Nerve Regeneration | 2 | 2020 | 71 | 0.550 |
Why?
|
| Astrocytes | 5 | 2023 | 259 | 0.510 |
Why?
|
| Models, Neurological | 1 | 2017 | 185 | 0.500 |
Why?
|
| Pharmacogenetics | 1 | 2017 | 197 | 0.490 |
Why?
|
| Microglia | 2 | 2020 | 129 | 0.480 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 3 | 2024 | 66 | 0.480 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2016 | 84 | 0.460 |
Why?
|
| Adenosine Triphosphate | 1 | 2016 | 267 | 0.460 |
Why?
|
| Mice | 20 | 2025 | 17590 | 0.460 |
Why?
|
| Dendrites | 5 | 1999 | 174 | 0.430 |
Why?
|
| Adult Stem Cells | 2 | 2021 | 52 | 0.430 |
Why?
|
| Systems Biology | 2 | 2011 | 60 | 0.410 |
Why?
|
| Apoptosis | 4 | 2020 | 1802 | 0.400 |
Why?
|
| Energy Metabolism | 1 | 2018 | 761 | 0.390 |
Why?
|
| Antidepressive Agents | 3 | 2024 | 313 | 0.380 |
Why?
|
| Neurodegenerative Diseases | 1 | 2015 | 271 | 0.380 |
Why?
|
| Mass Spectrometry | 3 | 2024 | 351 | 0.360 |
Why?
|
| Humans | 40 | 2026 | 125950 | 0.360 |
Why?
|
| Molecular Imaging | 2 | 2024 | 61 | 0.350 |
Why?
|
| Cell Differentiation | 8 | 2023 | 1849 | 0.350 |
Why?
|
| Rett Syndrome | 2 | 2025 | 216 | 0.350 |
Why?
|
| Principal Component Analysis | 1 | 2011 | 151 | 0.340 |
Why?
|
| Single-Cell Analysis | 3 | 2025 | 317 | 0.340 |
Why?
|
| Pyramidal Cells | 4 | 2017 | 137 | 0.330 |
Why?
|
| Cognition | 2 | 2022 | 782 | 0.330 |
Why?
|
| Lipids | 2 | 2017 | 549 | 0.330 |
Why?
|
| Mice, Inbred C57BL | 9 | 2024 | 4505 | 0.330 |
Why?
|
| Signal Transduction | 4 | 2018 | 4462 | 0.310 |
Why?
|
| Mice, Transgenic | 5 | 2021 | 2317 | 0.290 |
Why?
|
| Exocytosis | 2 | 1998 | 63 | 0.290 |
Why?
|
| Brain Chemistry | 2 | 2024 | 111 | 0.280 |
Why?
|
| Intelligence | 1 | 2008 | 91 | 0.280 |
Why?
|
| Glutathione | 2 | 2018 | 192 | 0.260 |
Why?
|
| Kidney | 2 | 2024 | 1262 | 0.250 |
Why?
|
| Aging | 3 | 2021 | 1194 | 0.240 |
Why?
|
| Liver | 2 | 2024 | 1755 | 0.240 |
Why?
|
| Schizophrenia | 1 | 2008 | 323 | 0.230 |
Why?
|
| Fatty Acids | 1 | 2007 | 350 | 0.230 |
Why?
|
| Cell Proliferation | 6 | 2022 | 2390 | 0.230 |
Why?
|
| Demyelinating Diseases | 1 | 2005 | 65 | 0.230 |
Why?
|
| Polysomnography | 1 | 2026 | 146 | 0.220 |
Why?
|
| Central Nervous System Diseases | 1 | 2005 | 95 | 0.220 |
Why?
|
| Duloxetine Hydrochloride | 1 | 2024 | 14 | 0.220 |
Why?
|
| Glutamic Acid | 2 | 2016 | 200 | 0.220 |
Why?
|
| Multiple Sclerosis | 2 | 2024 | 369 | 0.220 |
Why?
|
| Calcium | 2 | 1998 | 1021 | 0.200 |
Why?
|
| Polyadenylation | 1 | 2024 | 46 | 0.200 |
Why?
|
| Cluster Analysis | 2 | 2023 | 409 | 0.200 |
Why?
|
| Stem Cell Transplantation | 1 | 2005 | 225 | 0.200 |
Why?
|
| Spleen | 1 | 2024 | 250 | 0.200 |
Why?
|
| Sleep Wake Disorders | 1 | 2026 | 188 | 0.200 |
Why?
|
| Fluorescent Dyes | 4 | 2018 | 249 | 0.200 |
Why?
|
| Social Determinants of Health | 1 | 2024 | 147 | 0.190 |
Why?
|
| Sleep | 1 | 2026 | 350 | 0.190 |
Why?
|
| Cosmic Radiation | 1 | 2022 | 12 | 0.190 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2024 | 134 | 0.190 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 2 | 2013 | 41 | 0.190 |
Why?
|
| Oleic Acid | 1 | 2022 | 15 | 0.190 |
Why?
|
| Radiation Protection | 1 | 2022 | 48 | 0.190 |
Why?
|
| Cells, Cultured | 7 | 2018 | 2901 | 0.190 |
Why?
|
| Radiation Exposure | 1 | 2022 | 42 | 0.180 |
Why?
|
| Gene Duplication | 1 | 2023 | 364 | 0.180 |
Why?
|
| Algorithms | 4 | 2024 | 1635 | 0.180 |
Why?
|
| Space Flight | 1 | 2022 | 98 | 0.170 |
Why?
|
| Antigens, Differentiation | 1 | 2021 | 62 | 0.170 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2021 | 63 | 0.170 |
Why?
|
| Biology | 1 | 2021 | 25 | 0.170 |
Why?
|
| Stem Cell Niche | 1 | 2021 | 58 | 0.170 |
Why?
|
| Rats | 7 | 2020 | 3388 | 0.170 |
Why?
|
| Adult | 11 | 2025 | 30262 | 0.170 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2026 | 522 | 0.160 |
Why?
|
| Embryonic Stem Cells | 2 | 2014 | 162 | 0.160 |
Why?
|
| Microsomes, Liver | 1 | 2020 | 96 | 0.160 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2022 | 313 | 0.160 |
Why?
|
| Cytoskeletal Proteins | 1 | 2021 | 274 | 0.160 |
Why?
|
| Kainic Acid | 2 | 2016 | 21 | 0.150 |
Why?
|
| Pseudopodia | 1 | 1999 | 7 | 0.150 |
Why?
|
| Nerve Tissue Proteins | 3 | 2021 | 1075 | 0.150 |
Why?
|
| Models, Animal | 1 | 2021 | 454 | 0.150 |
Why?
|
| Transcriptome | 2 | 2022 | 1064 | 0.150 |
Why?
|
| Mutation | 3 | 2023 | 5924 | 0.140 |
Why?
|
| Golgi Apparatus | 1 | 1998 | 90 | 0.140 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 1999 | 130 | 0.140 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1998 | 101 | 0.140 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2020 | 974 | 0.140 |
Why?
|
| Cell Cycle | 2 | 2017 | 584 | 0.140 |
Why?
|
| Long-Term Potentiation | 1 | 1998 | 105 | 0.140 |
Why?
|
| Apolipoproteins D | 1 | 2017 | 4 | 0.140 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2020 | 231 | 0.140 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2017 | 34 | 0.140 |
Why?
|
| Apolipoprotein E4 | 1 | 2017 | 47 | 0.130 |
Why?
|
| Fluorometry | 1 | 2017 | 24 | 0.130 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2008 | 128 | 0.130 |
Why?
|
| Green Fluorescent Proteins | 4 | 2010 | 376 | 0.130 |
Why?
|
| Lipid Droplets | 1 | 2017 | 50 | 0.130 |
Why?
|
| Glycolysis | 1 | 2018 | 162 | 0.130 |
Why?
|
| Organ of Corti | 1 | 2016 | 27 | 0.130 |
Why?
|
| Thyroid Hormone Receptors alpha | 1 | 2016 | 10 | 0.130 |
Why?
|
| Thyroid Hormone Receptors beta | 1 | 2016 | 17 | 0.130 |
Why?
|
| Cognitive Dysfunction | 1 | 2021 | 282 | 0.130 |
Why?
|
| CX3C Chemokine Receptor 1 | 1 | 2016 | 11 | 0.130 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2018 | 281 | 0.130 |
Why?
|
| Receptors, CCR2 | 1 | 2016 | 23 | 0.120 |
Why?
|
| Receptors, Chemokine | 1 | 2016 | 46 | 0.120 |
Why?
|
| Synapses | 2 | 1999 | 430 | 0.120 |
Why?
|
| Male | 14 | 2026 | 62094 | 0.120 |
Why?
|
| Leukocyte Common Antigens | 1 | 2016 | 83 | 0.120 |
Why?
|
| Sindbis Virus | 2 | 2010 | 10 | 0.120 |
Why?
|
| Neuroglia | 1 | 2017 | 206 | 0.120 |
Why?
|
| Entorhinal Cortex | 1 | 2015 | 27 | 0.120 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2016 | 72 | 0.120 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2018 | 560 | 0.110 |
Why?
|
| Proton Magnetic Resonance Spectroscopy | 1 | 2015 | 29 | 0.110 |
Why?
|
| Amino Acids | 1 | 2018 | 614 | 0.110 |
Why?
|
| Psychomotor Agitation | 1 | 2015 | 55 | 0.110 |
Why?
|
| Proteins | 2 | 2018 | 1019 | 0.110 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 489 | 0.110 |
Why?
|
| Thalamus | 1 | 2015 | 77 | 0.110 |
Why?
|
| Potassium Channels | 1 | 1995 | 150 | 0.110 |
Why?
|
| Prefrontal Cortex | 1 | 2016 | 207 | 0.110 |
Why?
|
| Monocytes | 1 | 2016 | 329 | 0.110 |
Why?
|
| HMGB2 Protein | 1 | 2013 | 2 | 0.110 |
Why?
|
| Intestines | 1 | 2018 | 580 | 0.110 |
Why?
|
| Homeostasis | 1 | 2018 | 685 | 0.100 |
Why?
|
| Adipose Tissue | 1 | 2016 | 475 | 0.100 |
Why?
|
| Aging, Premature | 1 | 2013 | 30 | 0.100 |
Why?
|
| Tetraspanins | 1 | 2013 | 33 | 0.100 |
Why?
|
| Visual Cortex | 1 | 2014 | 111 | 0.100 |
Why?
|
| Thinking | 1 | 2013 | 31 | 0.100 |
Why?
|
| Leukoencephalopathies | 1 | 2013 | 60 | 0.100 |
Why?
|
| Models, Biological | 1 | 2017 | 1374 | 0.100 |
Why?
|
| Frontal Lobe | 1 | 2013 | 114 | 0.100 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2014 | 314 | 0.100 |
Why?
|
| Genetic Variation | 1 | 2018 | 1520 | 0.090 |
Why?
|
| Language Development Disorders | 1 | 2013 | 177 | 0.090 |
Why?
|
| Sequence Deletion | 1 | 2013 | 510 | 0.090 |
Why?
|
| Seizures | 1 | 2016 | 850 | 0.090 |
Why?
|
| Depressive Disorder, Major | 1 | 2016 | 424 | 0.090 |
Why?
|
| Brain Mapping | 1 | 2013 | 384 | 0.080 |
Why?
|
| Electroencephalography | 2 | 2026 | 843 | 0.080 |
Why?
|
| Metabolome | 1 | 2013 | 318 | 0.080 |
Why?
|
| Brain Injuries | 1 | 2016 | 692 | 0.080 |
Why?
|
| Membrane Proteins | 1 | 2018 | 1549 | 0.080 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2011 | 242 | 0.080 |
Why?
|
| Immunohistochemistry | 3 | 2017 | 1603 | 0.080 |
Why?
|
| Staining and Labeling | 1 | 2010 | 168 | 0.080 |
Why?
|
| Cohort Studies | 3 | 2026 | 4892 | 0.080 |
Why?
|
| Transduction, Genetic | 1 | 2010 | 282 | 0.080 |
Why?
|
| Base Sequence | 1 | 2013 | 2773 | 0.080 |
Why?
|
| Female | 12 | 2026 | 67908 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 2330 | 0.070 |
Why?
|
| Age of Onset | 2 | 2024 | 609 | 0.070 |
Why?
|
| Child | 6 | 2026 | 25070 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2014 | 871 | 0.070 |
Why?
|
| Microscopy, Confocal | 2 | 2018 | 361 | 0.070 |
Why?
|
| Epilepsy | 1 | 2015 | 843 | 0.070 |
Why?
|
| Cognition Disorders | 1 | 2011 | 542 | 0.070 |
Why?
|
| Adolescent | 4 | 2026 | 19942 | 0.070 |
Why?
|
| Glucosyltransferases | 2 | 2018 | 41 | 0.070 |
Why?
|
| Hair Follicle | 1 | 2007 | 33 | 0.070 |
Why?
|
| Protons | 1 | 2007 | 94 | 0.070 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2015 | 806 | 0.060 |
Why?
|
| HeLa Cells | 2 | 2018 | 689 | 0.060 |
Why?
|
| Young Adult | 4 | 2025 | 9596 | 0.060 |
Why?
|
| Sleep Stages | 1 | 2026 | 31 | 0.060 |
Why?
|
| Brain Diseases | 1 | 2008 | 280 | 0.060 |
Why?
|
| Mice, Knockout | 3 | 2020 | 3705 | 0.060 |
Why?
|
| Child, Preschool | 4 | 2026 | 14350 | 0.060 |
Why?
|
| Prosencephalon | 1 | 2024 | 36 | 0.050 |
Why?
|
| Activation, Metabolic | 1 | 2024 | 4 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2024 | 364 | 0.050 |
Why?
|
| Down Syndrome | 1 | 2026 | 200 | 0.050 |
Why?
|
| Moon | 1 | 2022 | 13 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 3250 | 0.050 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2022 | 19 | 0.050 |
Why?
|
| White Matter | 1 | 2024 | 205 | 0.050 |
Why?
|
| Spatial Analysis | 1 | 2022 | 28 | 0.050 |
Why?
|
| Luminescent Proteins | 2 | 1999 | 155 | 0.050 |
Why?
|
| Sequence Analysis, RNA | 1 | 2024 | 416 | 0.040 |
Why?
|
| Ligands | 1 | 2022 | 478 | 0.040 |
Why?
|
| Atomoxetine Hydrochloride | 1 | 2020 | 15 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2005 | 1107 | 0.040 |
Why?
|
| RNA | 1 | 2024 | 526 | 0.040 |
Why?
|
| Receptors, Purinergic P2Y12 | 1 | 2020 | 5 | 0.040 |
Why?
|
| c-Mer Tyrosine Kinase | 1 | 2020 | 11 | 0.040 |
Why?
|
| Norepinephrine | 1 | 2020 | 152 | 0.040 |
Why?
|
| Synaptic Transmission | 2 | 1999 | 318 | 0.040 |
Why?
|
| Culture Media, Conditioned | 1 | 2020 | 82 | 0.040 |
Why?
|
| Feedback, Physiological | 1 | 2020 | 67 | 0.040 |
Why?
|
| Microscopy, Video | 1 | 1999 | 19 | 0.040 |
Why?
|
| 2-Amino-5-phosphonovalerate | 1 | 1999 | 14 | 0.040 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2020 | 112 | 0.040 |
Why?
|
| Culture Techniques | 1 | 1999 | 74 | 0.040 |
Why?
|
| Synaptic Membranes | 1 | 1999 | 21 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2020 | 344 | 0.040 |
Why?
|
| Intracellular Space | 1 | 2018 | 47 | 0.040 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 1998 | 33 | 0.040 |
Why?
|
| Pyridinium Compounds | 1 | 1998 | 27 | 0.040 |
Why?
|
| Organelles | 1 | 1998 | 21 | 0.040 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 1999 | 95 | 0.040 |
Why?
|
| Electric Stimulation | 1 | 1999 | 238 | 0.040 |
Why?
|
| Microscopy | 1 | 1999 | 127 | 0.040 |
Why?
|
| Morphogenesis | 1 | 1999 | 190 | 0.040 |
Why?
|
| In Vitro Techniques | 2 | 1999 | 821 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2018 | 305 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2020 | 240 | 0.030 |
Why?
|
| Fatty Acid Transport Proteins | 1 | 2017 | 11 | 0.030 |
Why?
|
| Apolipoprotein E2 | 1 | 2017 | 16 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 420 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 1998 | 139 | 0.030 |
Why?
|
| Cell Count | 1 | 2017 | 218 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2017 | 103 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 2865 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2026 | 16782 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2017 | 413 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2017 | 229 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2018 | 324 | 0.030 |
Why?
|
| Triiodothyronine | 1 | 2016 | 54 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 1999 | 1131 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2016 | 224 | 0.030 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2018 | 291 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 2015 | 243 | 0.030 |
Why?
|
| Kinetics | 1 | 2017 | 1092 | 0.030 |
Why?
|
| Phosphocreatine | 1 | 2015 | 6 | 0.030 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2016 | 163 | 0.030 |
Why?
|
| Cell Survival | 1 | 2017 | 834 | 0.030 |
Why?
|
| Creatine | 1 | 2015 | 38 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 2016 | 137 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1995 | 262 | 0.030 |
Why?
|
| Atrophy | 1 | 2015 | 242 | 0.030 |
Why?
|
| Sample Size | 1 | 2015 | 83 | 0.030 |
Why?
|
| Glutamine | 1 | 2016 | 196 | 0.030 |
Why?
|
| Immunoblotting | 1 | 1995 | 291 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2018 | 571 | 0.030 |
Why?
|
| Lung | 1 | 2022 | 1509 | 0.030 |
Why?
|
| Reference Values | 1 | 2015 | 678 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2025 | 6167 | 0.030 |
Why?
|
| Lateral Ventricles | 1 | 2013 | 14 | 0.030 |
Why?
|
| Telomerase | 1 | 2014 | 153 | 0.030 |
Why?
|
| Neuronal Plasticity | 1 | 2016 | 281 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2013 | 119 | 0.020 |
Why?
|
| DNA Primers | 1 | 2013 | 603 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2013 | 418 | 0.020 |
Why?
|
| Cell Membrane | 1 | 1995 | 447 | 0.020 |
Why?
|
| Axons | 1 | 2016 | 372 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2016 | 822 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2013 | 309 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 3472 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2013 | 1019 | 0.020 |
Why?
|
| Cell Line | 1 | 2016 | 2568 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 1995 | 1014 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 1349 | 0.020 |
Why?
|
| Fetus | 1 | 1995 | 578 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2014 | 661 | 0.020 |
Why?
|
| Age Factors | 1 | 2017 | 2762 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 1236 | 0.020 |
Why?
|
| Exons | 1 | 2013 | 757 | 0.020 |
Why?
|
| Gene Expression | 1 | 1995 | 1489 | 0.020 |
Why?
|
| Middle Aged | 3 | 2015 | 27337 | 0.020 |
Why?
|
| Pedigree | 1 | 2013 | 1655 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 3600 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 3297 | 0.020 |
Why?
|
| Intermediate Filament Proteins | 1 | 2007 | 23 | 0.020 |
Why?
|
| Nestin | 1 | 2007 | 15 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2013 | 1739 | 0.020 |
Why?
|
| Chick Embryo | 1 | 2007 | 113 | 0.020 |
Why?
|
| Clone Cells | 1 | 2007 | 164 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 2919 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2010 | 892 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 4428 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 6579 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2015 | 8374 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2007 | 1780 | 0.010 |
Why?
|
| Dissection | 1 | 1999 | 58 | 0.010 |
Why?
|
| Photons | 1 | 1999 | 55 | 0.010 |
Why?
|
| Lasers | 1 | 1999 | 108 | 0.010 |
Why?
|
| Aged | 1 | 2015 | 20039 | 0.010 |
Why?
|
| Equipment Design | 1 | 1999 | 582 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1999 | 724 | 0.010 |
Why?
|